Pakistan Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Pakistan Pharmaceuticals and Healthcare Report

Pakistan Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Pakistan Pharmaceuticals and Healthcare Report
Published May 28, 2016
107 pages — Published May 28, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In February ----, Pakistan authorised the import of Sovaldi (sofosbuvir) for the treatment of hepatitis C. Health officials in the country note that some -mn people have the condition and is the cause of approximately --,--- deaths. In April ----, the Sindh High Court reserved its verdict regarding the fixing of retail prices for hepatitis C treatments. ...In April ----, the Sindh High Court reserved its verdict regarding the fixing of retail prices for hepatitis C treatments. This follows claims by drugmakers that the drug committee had recommended fixing the price of a sofosbuvir tablet at PKR-,--- but the government fixing the retail price at PKR-,---. This follows claims by drugmakers that the drug committee had recommended fixing the price of a sofosbuvir tablet at PKR-,--- but the government fixing the retail price at PKR-,---. Under this programme, --,--- families were selected and will be given free healthcare services at facilities in the programme. The programme is expected to expand to all parts of Balochistan, Punjab, Azad Kashmir,

...BMI View: Healthcare expenditure in Pakistan will grow strongly, albeit from a low base. Central to this trajectory is the rise in household incomes as out-of-pocket health spending remains a dominant source of healthcare financing. ...BMI View: Healthcare expenditure in Pakistan will grow strongly, albeit from a low base. Central to this trajectory is the rise in household incomes as out-of-pocket health spending remains a dominant source of healthcare financing. This is further supported by the higher health expenditure by administrative unit authorities which have outlined long-term medical strategies. ...This is further supported by the higher health expenditure by administrative unit authorities which have outlined long-term medical strategies. At the sub-national level, the strongest commercial prospects for pharmaceutical and medical device companies will be in the more economically developed provinces of Punjab and Sindh.

...All information contained in this publication is copyrighted in the name of Business Monitor International Ltd, and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. ...

...

  
Source:
Document ID
1748-2089
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Pakistan Pharmaceuticals and Healthcare Report" May 28, 2016. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Pakistan-Pharmaceuticals-and-Healthcare-Report-2026-118>
  
APA:
Business Monitor International - Industry Reports. (2016). Pakistan Pharmaceuticals and Healthcare Report May 28, 2016. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Pakistan-Pharmaceuticals-and-Healthcare-Report-2026-118>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.